FTC sues main pharmacy advantage professionals around insulin rates The agency brought motion versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the checklist cost of existence-preserving insulin prescription drugs. This system aligns with These initiatives, the ONC explained. The market is tackling https://paxtonulbsi.xzblogs.com/71831991/healthcare-news-an-overview